E-LIB Suche - Ergebnisse für: Hamrén, Ulrika Wählby

1

Author Correction: Molecular and phenotypic characteristics..:

Ahani, Bahar ; Tuffy, Kevin M. ; Aksyuk, Anastasia A....
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

2

Population Pharmacokinetics of Nirsevimab in Preterm and Te..:

Clegg, Lindsay ; Freshwater, Ed ; Leach, Amanda..
The Journal of Clinical Pharmacology. 64 (2024) 5 - p. 555-567 , 2024

Link: https://doi.org/10.1002/..

3

Molecular and phenotypic characteristics of RSV infections ..:

Ahani, Bahar ; Tuffy, Kevin M. ; Aksyuk, Anastasia A....
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

1934. Nirsevimab is Associated with Higher and More Sustain..:

Wilkins, Deidre ; Hamrén, Ulrika Wählby ; Chang, Yue...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

5

LB13. The Efficacy and Impact in Heathy Infants of Nirsevim..:

Hammitt, Laura ; Hammitt, Laura ; Dagan, Ron...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S811-S812 , 2021

Link: https://doi.org/10.1093/..

6

Efficacy and safety of AZD7594, an inhaled non-steroidal se..:

Brown, Mary N. ; Fuhr, Rainard ; Beier, Jutta...
Respiratory Research. 20 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

7

Pharmacokinetics of the Inhaled Selective Glucocorticoid Re..:

Melin, Johanna ; Prothon, Susanne ; Kloft, Charlotte...
The AAPS Journal. 19 (2017) 3 - p. 865-874 , 2017

Link: https://doi.org/10.1208/..

8

Pharmacokinetic-pharmacodynamic modeling of fostamatinib ef..:

Maringwa, John ; Kågedal, Matts ; Hamrén, Ulrika Wählby...
The Journal of Clinical Pharmacology. 55 (2014) 3 - p. 328-335 , 2014

Link: https://doi.org/10.1002/..

9

Comprehensive Summary of Safety Data on Nirsevimab in Infan..:

Mankad, Vaishali S. ; Leach, Amanda ; Chang, Yue...
Pathogens. 13 (2024) 6 - p. 503 , 2024

Link: https://doi.org/10.3390/..

10

Efficacy of nirsevimab against respiratory syncytial virus ..:

Simões, Eric A F ; Madhi, Shabir A ; Muller, William J...
The Lancet Child & Adolescent Health. 7 (2023) 3 - p. 180-189 , 2023

Link: https://doi.org/10.1016/..

11

Safety of Re-dosing Nirsevimab Prior to RSV Season 2 in Chi..:

Domachowske, Joseph B ; Chang, Yue ; Atanasova, Victoria...
Journal of the Pediatric Infectious Diseases Society. 12 (2023) 8 - p. 477-480 , 2023

Link: https://doi.org/10.1093/..

12

The novel bronchodilator navafenterol: a phase 2a, multicen..:

Singh, Dave ; Beier, Jutta ; Astbury, Carol...
European Respiratory Journal. 59 (2021) 4 - p. 2100972 , 2021

Link: https://doi.org/10.1183/..

13

Longitudinal FEV1 and Exacerbation Risk in COPD: Quantifyin..:

Zhudenkov, Kirill ; Palmér, Robert ; Jauhiainen, Alexandra...
International Journal of Chronic Obstructive Pulmonary Disease. 16 (2021) - p. 101-111 , 2021

Link: https://doi.org/10.2147/..

14

Safety, pharmacokinetics and pharmacodynamics of the select..:

Prothon, Susanne ; Wählby Hamrén, Ulrika ; Tehler, Ulrika...
Drug Design, Development and Therapy. 13 (2019) - p. 3845-3853 , 2019

Link: https://doi.org/10.2147/..

15

Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD..:

Cullberg, Marie ; Arfvidsson, Cecilia ; Larsson, Bengt...
Drugs in R&D. 18 (2018) 2 - p. 149-159 , 2018

Link: https://doi.org/10.1007/..